Markets:

Overview

News

Currencies

International

Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.180 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

February 28, 2024

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

January 04, 2024

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 13, 2023

Via Benzinga

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

December 13, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

What 6 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗

September 12, 2023

Via Benzinga

Where Black Diamond Therapeutic Stands With Analysts ↗

July 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 08, 2023

Via Benzinga

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

November 07, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 06, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying ↗

October 20, 2023

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535

October 14, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 04, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

Black Diamond Therapeutics Announces CEO Transition

September 18, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer

September 11, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

September 05, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 11, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗

July 14, 2023

Via Benzinga

$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

July 10, 2023

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

July 10, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying ↗

July 07, 2023

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗

July 05, 2023

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.

Via Benzinga

Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics ↗

June 30, 2023

Tuesday, Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial clinical data from the dose escalation portion of Phase 1 clinical study of BDTX-1535 for non-small cell lung cancer (NSCLC)

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying ↗

June 30, 2023

Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 30, 2023

It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!

Via InvestorPlace

Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock

June 29, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Why Shares of Black Diamond Therapeutics Skyrocketed This Week ↗

June 29, 2023

The company announced positive early-trial news for non-small cell lung cancer.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 29, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.